The neuroprotective agent DP-b99 does not interact with s-warfarin in vivo despite significant CYP2C9 inhibition in vitro
- Basic Clin Pharmacol Toxicol. 2011 Apr;108(4):289-92. doi: 10.1111/j.1742-7843.2010.00654.x.
Affiliations
- 1. D-Pharm Ltd., Rehovot, Israel. [email protected]
PMID: 21414144
DOI: 10.1111/j.1742-7843.2010.00654.x
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Neurological Disease